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Central neuronal functions of histamine H4 receptors
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The human histamine H4 receptor (H4R), the most 
recently discovered histamine receptor, is predominantly 
expressed on inflammatory cells and lymphoid tissues and 
characterized as the immune system histamine receptor 
with a pro-inflammatory role. The occurrence of H4R on 
human and rodent neurons has also been recently reported, 
but, conversely to the well-characterized immunological 
role of the peripheral H4R, much less is known about its 
functions in the central nervous system (CNS).
The expression and neuronal role of H4R has been 
controversially discussed since its discovery. The human 
and rat H4R mRNA and protein were detected in dorsal 
root ganglia (DRG), spinal cord and several brain regions 
[1, 2], but the difficulty to generate H4R antibodies with 
high specificity generates results that should be interpreted 
with some caution. Some indication for a functional role 
in the CNS for this receptor came from studies with 
selective ligands [3, 4]. However, in the absence of 
knockout controls, off-target effects of the H4R ligands 
cannot be fully excluded. Although H4R-deficient mice 
were generated more than a decade ago, they have not 
been used to elucidate the physiopathological role of this 
receptor subtype in the CNS. The study of Sanna et al. [5] 
is the first investigation on the functional role of neuronal 
H4R through the characterization of the behavioural 
phenotype of H4R-deficient mice. 
Authors [6] showed that a prominent role of neuronal 
H4R appears to be the modulation of pain perception. 
In human and rodents, expression of H4R mRNA is the 
highest in the spinal cord and H4R protein is strongly 
expressed in sensory neurons of DRG and in the lumbar 
spinal cord, especially laminae I and II [1, 2], consistent 
with a role of H4R in pain perception. Conversely to 
what expected from the pro-nociceptive profile obtained 
by peripheral H4R stimulation, H4R-deficient mice had 
unaltered sensitivity to thermal and mechanical stimuli, 
and showed increased pain hypersensitivity in the presence 
of a peripheral neuropathy. This hypernociceptive 
phenotype indicates an involvement of neuronal H4R in 
the response to a condition of pathological chronic pain 
of neuronal origin rather than in the regulation of the 
physiological maintenance of the pain threshold. A dual 
role of neuronal and peripheral H4R on pain processes 
can be postulated: pain-reducing activity by neuronal H4R 
stimulation, pain-promoting pro-inflammatory effects by 
peripheral H4R stimulation.
A role of the histaminergic system in the modulation 
of anxiety has been suggested, but investigations produced 
contradictory results and opposite roles for histamine 
H1R, H2R and H3R subtypes have been reported [6]. 
H4R deficiency exacerbated the response to an anxiety-
provoking environment. This anxiogenic-like phenotype of 
H4R-deficient mice indicates a positive effect of neuronal 
H4R stimulation on anxiety management. This hypothesis 
was supported by the anxiolytic-like effects produced by 
centrally administered H4R agonists in behavioural tasks 
in mice [4]. 
Brain histamine plays a fundamental role in eating 
behaviour and induces loss of appetite and suppression 
of food intake mainly via H1R [6]. H4R-deficient mice 
showed an increase in food intake, consistent with 
the reduction of food consumption observed after 
intracerebroventricular administration of the H4R full 
agonist VUF 8430. Neuronal H4R might, thus, exert a 
synergic action with H1R in the histaminergic regulation 
of eating behaviour. 
The histaminergic system is known to be involved 
in the regulation of locomotor activity. Histidine 
decarboxylase, H1R, H2R and H3R knockout mice showed 
reduced locomotor activity [7]. Conversely, behavioural 
characterization of H4R-deficient mice showed an increase 
in ambulation in an open field and in exploratory activity, 
revealing an increased spontaneous locomotor activity. 
These findings highlight a role of H4R on motor behaviour 
at odds with that observed for the other histamine receptor 
subtypes. 
The study of Sanna et al. [6] illustrated a peculiar and 
selective behavioural profile of H4R-deficient mice with a 
modest or absent involvement of H4R in some of neuronal 
functions modulated by the histaminergic system, such as 
depression and memory. Pharmacological or genetic loss 
of histamine or histamine receptor function in animals 
produces phenotypes that model human depression [6]. 
H4R-deficient mice had higher immobility time than wild 
type mice in a behavioural despair paradigm, showing a 
depressant-like response. However, in the same testing 
environment, central administration of H4R agonists was 
devoid of any antidepressant-like activity, suggesting a 
minor role of H4R in depression. Authors observed that 
H4R deficiency induces an anxiogenic-like behaviour 
and the increased immobility time recorded might be a 
response to an anxiety-promoting environment rather than 
a depressant-like response. Findings on H4R-deficient 
mice also exclude an outstanding role of H4R in the 
histaminergic modulation of memory processes. Although 
histaminergic neurons project to regions important for 
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cognitive functions, H4R-deficient mice did not show any 
alteration of both working and recognition memory.
Characterization of the behavioural phenotype of 
H4R-deficient mice assessed a functional role of neuronal 
H4R and highlighted the importance of its integrity in the 
histaminergic regulation of important neurophysiological 
functions, including pain sensitivity and anxiety. Since 
the identification of H4R, several ligands activating this 
receptor have been described and more compounds are 
in development. Targeting neuronal H4R with selective 
agonists might be a clinical relevant therapeutic approach 
to be exploited to relieve neuropathic pain and to better 
manage anxiety and anxiety-related disorders.
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